The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss
Authors:
- 8 January 2011
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 268 (6) , 833-839
Abstract
The effect of intratympanic steroid injection is controversial as salvage or initial treatment option for sudden sensorineural hearing loss (SSNHL) and almost unknown if it is consecutively to use after initial systemic steroids. This study aimed to analyze the efficiency of intratympanic dexamethasone injection (ITDI) as a sequential treatment in the patients who failed initial systemic steroid treatments for SSNHL. Forty-six patients with SSNHL who did not respond to initial systemic steroids were prospectively included in the study. The patients were randomly classified into two groups; the ITDI group (21 patients) did not take four sequential ITDI within 2 weeks after systemic steroids, and the control group (25 patients) took any more medications. Hearing improvement was defined as a 10 dB or more decrease in the pure tone average (PTA) of the four-frequencies (0.5, 1, 2, and 3 kHz). Hearing improvement was observed in 10 (47.6%) of 21 ITDI patients and in 4 (16.0%) of 25 control patients (P = 0.027). An improvement of the mean PTA was 11.4 dB in the ITDI group and 1.7 dB in the control group (P = 0.004). The ITDI group showed significant hearing improvement at low frequency (500 Hz) than the control group. The patients with 70 or more dB in PTA before ITDI showed significant hearing improvement than the other patients with better PTAs (P = 0.038). The sequential ITDI, which is performed immediately after initial systemic steroid therapy, may be a simple, effective second-line treatment of choice for the patients who show poor response to initial treatments for SSNHL.Keywords
This publication has 22 references indexed in Scilit:
- Generation of highly-reactive oxygen species is closely related to hair cell damage in rat organ of corti treated with gentamicinNeuroscience, 2009
- Issues, indications, and controversies regarding intratympanic steroid perfusionCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2008
- Combination Therapy (Intratympanic Dexamethasone + High-Dose Prednisone Taper) for the Treatment of Idiopathic Sudden Sensorineural Hearing LossOtology & Neurotology, 2008
- Can Intratympanic Dexamethasone Added to Systemic Steroids Improve Hearing Outcome in Patients With Sudden Deafness?The Laryngoscope, 2008
- Apoptotic Pattern of Cochlear Outer Hair Cells and Frequency-specific Hearing Threshold Shift in Noise-exposed BALB/c MiceClinical and Experimental Otorhinolaryngology, 2008
- Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafnessActa Oto-Laryngologica, 2008
- Intratympanic Dexamethasone for Sudden Sensorineural Hearing Loss After Failure of Systemic TherapyThe Laryngoscope, 2007
- Comparison of Intratympanic and Intravenous Dexamethasone Treatment on Sudden Sensorineural Hearing Loss with DiabetesOtology & Neurotology, 2006
- Intratympanic Dexamethasone Injection for Refractory Sudden Sensorineural Hearing LossThe Laryngoscope, 2006
- Intratympanic Dexamethasone and Hyaluronic Acid in Patients with Low-Frequency and Ménière's-Associated Sudden Sensorineural Hearing LossOtology & Neurotology, 2005